Rein Therapeutics Inc.
RNTX
$0.83
-$0.04-4.06%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -49.76M | -50.21M | -49.87M | -58.89M | -59.15M |
| Total Depreciation and Amortization | 0.00 | 1.00K | 1.00K | 1.00K | 1.00K |
| Total Amortization of Deferred Charges | 1.08M | 623.00K | -- | -- | -- |
| Total Other Non-Cash Items | 31.59M | 31.27M | 31.37M | 39.50M | 38.16M |
| Change in Net Operating Assets | -1.74M | 1.71M | -865.00K | -1.57M | -235.00K |
| Cash from Operations | -18.83M | -16.61M | -19.36M | -20.95M | -21.22M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -35.07M | -- | -- | -- | -- |
| Cash from Investing | -35.07M | -- | -- | -- | -- |
| Total Debt Issued | 4.30M | 4.30M | 0.00 | 1.90M | -- |
| Total Debt Repaid | -5.38M | -- | -- | -- | -- |
| Issuance of Common Stock | 55.00M | 3.06M | 3.44M | 1.99M | 1.99M |
| Repurchase of Common Stock | -- | -- | -- | -- | -251.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 2.85M | 6.32M | 6.32M | 3.47M | 3.27M |
| Cash from Financing | 56.77M | 13.67M | 9.76M | 7.35M | 5.01M |
| Foreign Exchange rate Adjustments | -49.00K | -44.00K | -44.00K | -27.00K | -1.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.82M | -2.98M | -9.65M | -13.63M | -16.22M |